Biohaven Pharmaceutical Holding Co. Ltd.
(NYSE : BHVN)

( )
BHVN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.14%148.450.7%$817.55m
BMYBristol-Myers Squibb Co. -0.82%66.881.0%$766.87m
PFEPfizer Inc. 1.29%40.710.9%$619.15m
MRKMerck & Co., Inc. -1.26%88.520.7%$606.57m
ABBVAbbVie, Inc. -2.23%85.272.3%$577.01m
LLYEli Lilly & Co. -0.27%141.181.1%$410.25m
NVSNovartis AG -0.31%94.920.2%$122.34m
APLSApellis Pharmaceuticals, Inc. -0.42%42.290.0%$116.99m
GSKGlaxoSmithKline Plc 0.08%47.830.2%$97.55m
AZNAstraZeneca Plc -0.48%50.211.2%$92.99m
KRTXKaruna Therapeutics, Inc. -13.46%99.750.0%$72.42m
NVONovo Nordisk A/S 0.46%61.600.1%$67.09m
SNYSanofi 0.41%49.600.2%$61.96m
RETAReata Pharmaceuticals, Inc. -1.40%206.823.5%$61.74m
ENDPEndo International Plc 4.35%6.608.8%$47.74m

Company Profile

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.